1. Home
  2. INTS vs CARV Comparison

INTS vs CARV Comparison

Compare INTS & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • CARV
  • Stock Information
  • Founded
  • INTS 2012
  • CARV 1948
  • Country
  • INTS United States
  • CARV United States
  • Employees
  • INTS N/A
  • CARV N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • CARV Savings Institutions
  • Sector
  • INTS Health Care
  • CARV Finance
  • Exchange
  • INTS Nasdaq
  • CARV Nasdaq
  • Market Cap
  • INTS 12.2M
  • CARV 14.5M
  • IPO Year
  • INTS 2023
  • CARV 1994
  • Fundamental
  • Price
  • INTS $0.42
  • CARV $1.58
  • Analyst Decision
  • INTS Strong Buy
  • CARV
  • Analyst Count
  • INTS 4
  • CARV 0
  • Target Price
  • INTS $4.50
  • CARV N/A
  • AVG Volume (30 Days)
  • INTS 87.5M
  • CARV 59.3K
  • Earning Date
  • INTS 11-06-2025
  • CARV 11-13-2025
  • Dividend Yield
  • INTS N/A
  • CARV N/A
  • EPS Growth
  • INTS N/A
  • CARV N/A
  • EPS
  • INTS N/A
  • CARV N/A
  • Revenue
  • INTS N/A
  • CARV $22,310,000.00
  • Revenue This Year
  • INTS N/A
  • CARV N/A
  • Revenue Next Year
  • INTS N/A
  • CARV N/A
  • P/E Ratio
  • INTS N/A
  • CARV N/A
  • Revenue Growth
  • INTS N/A
  • CARV N/A
  • 52 Week Low
  • INTS $0.19
  • CARV $1.30
  • 52 Week High
  • INTS $3.18
  • CARV $3.85
  • Technical
  • Relative Strength Index (RSI)
  • INTS 50.05
  • CARV 24.49
  • Support Level
  • INTS $0.38
  • CARV $1.41
  • Resistance Level
  • INTS $0.50
  • CARV $3.85
  • Average True Range (ATR)
  • INTS 0.07
  • CARV 0.31
  • MACD
  • INTS -0.02
  • CARV -0.24
  • Stochastic Oscillator
  • INTS 18.75
  • CARV 7.78

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About CARV Carver Bancorp Inc.

Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.

Share on Social Networks: